FdaApplication
BLA 761312
Identifiers
- fda_app_no: BLA761312
Properties
| Property | Value |
|---|---|
| applicant_name | Citius Oncology, Inc. |
| application_type | BLA |
| approval_date | 2024-08-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYMPHIR | DENILEUKIN DIFTITOX-CXDL | 300MCG | For Injection |
1 product